猪用口蹄疫O1/Campos与O/Primorsky/2014疫苗对抗O Mya-98系病毒的效力评价
研究评估两种O型商业疫苗(O1/Campos和O/Primorsky/2014)对韩国2014年分离的O/SKR/Jincheon/2014病毒(O/SEA/Mya-98系)的猪体内效力。攻击试验显示单次注射即诱导高异源病毒中和抗体滴度并成功保护SPF猪。田间试验表明8周龄首免最佳,两针组持续显著更高VNT滴度。
要点
- 两种O型疫苗单次注射即可诱导高异源VNT滴度并保护SPF猪免受攻击。
- 田间试验中12或14周龄接种未观察到20和24周龄时预期的血清学改善。
- 考虑母源抗体可提供保护,猪首免最佳年龄为8周龄;两针组VNT滴度持续显著更高。
核心结论
- 两种O型商业疫苗通过效力试验和田间试验证明在猪中有效。
- 单次注射即可诱导高异源VNT滴度并成功保护SPF猪免受O/SKR/Jincheon/2014病毒攻击。
研究设计与样本
- 两种O型商业疫苗(O1/Campos和O/Primorsky/2014)的体内效力评估。
- SPF猪异源病毒攻击试验,攻击病毒为韩国2014年分离的O/SKR/Jincheon/2014(O/SEA/Mya-98系)。
- 田间试验设三个单针组(8、12或14周龄注射)和一个两针组(8和12周龄注射)。
主要发现
- 两种疫苗单次注射即诱导高异源VNT滴度并成功保护SPF猪。
- 田间试验中12或14周龄接种未观察到20和24周龄时预期的血清学改善。
- 延迟接种导致14周龄时母源抗体耗竭。
- 两针接种组显示免疫猪VNT滴度持续显著更高。
关键数值与推荐
- 猪首免最佳年龄为8周龄,考虑母源抗体可提供对口蹄疫感染的保护性免疫。
临床怎么用
- 猪口蹄疫首免建议在8周龄进行,采用两针程序可获得持续显著更高的VNT滴度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Two type O commercial vaccines, the O1/Campos and O/Primorsky/2014 vaccines, were studied to evaluate the in vivo efficacy in pigs against heterologous virus challenge with the O/SKR/Jincheon/2014 virus (O/SEA/Mya-98 lineage) isolated in Korea in 2014. The in vivo challenge results indicated that both vaccines induced a high heterologous virus neutralization test (VNT) titer by a single injection and successfully protected specific pathogen-free (SPF) pigs from challenge infection. To determine the optimal vaccination age, a field trial with each vaccine was conducted with three one-shot-vaccinated groups that were injected at 8, 12, or 14 weeks of age and one two-shot-vaccinated group that was injected at 8 and 12 weeks of age in the pig farms. In these field trials, the improved serological performance at 20 and 24 weeks of age expected with vaccination at 12 or 14 weeks of age was not observed, although improved serological results were expected as the result of decreasing interference of maternally derived antibodies (MDAs), as MDAs waned with age. In addition, delayed vaccination resulted in MDA depletion at 14 weeks of age. Therefore, the optimal age for primary vaccination with two different formulated vaccines was 8 weeks old in pigs, considering that MDAs could provide a protective immunity against foot-and-mouth disease (FMD) infection. Prolonged significantly higher VNT titers of immunized pigs were demonstrated in the two-shot-vaccinated groups. In total, the effectiveness of the two vaccines was demonstrated through efficacy tests and field trials in pigs.
引用
- Choi J, Jo HJ, Jung SS, et al. Evaluation of swine protection with foot-and-mouth disease O1/Campos and O/Primorsky/2014 vaccines against the O Mya-98 lineage virus from East Asia. Vaccine. 2021. PMID: 33618945. doi:10.1016/j.vaccine.2021.02.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。